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Background: Recent evidence proved the necessity to improve health care and pain management in newborns.
Osteopathic manipulative treatment (OMT) has been largely used to treat painful syndromes as well as term and
preterm newborns. Recent studies have demonstrated positive results of osteopathy in reducing length of stay and
costs. However, no trials were carried out on pain in newborns. The aim of the present clinical trial is to explore the
effectiveness of osteopathic treatment in reducing pain in a sample of preterms.
Methods/design: A three-armed single blinded placebo-control randomised controlled trial protocol has been
designed to primarily evaluate the extent to which OMT is effective in reducing pain in preterms. One hundred and
twenty newborns will be enrolled from one tertiary neonatal intensive care unit in central Italy and randomised in
three groups: study, sham and control. The study group will be further prospectively randomised in two subgroups:
experienced osteopaths and students. All preterms will receive standard medical care. Osteopathic treatment will
be applied to the study group only whilst ‘soft touch’ will be administer to the sham group only. Newborns will
undergo manual sessions once a week for the entire period of hospitalisation. Blinding will be assured for neonatal
staff and outcome assessor. Primary outcome will be the mean difference in baseline score changes of PIPP questionnaire
between discharge and entry among the three groups. Secondary outcomes will be: mean difference in length
of stay and costs between groups. Statistical analyses will use per-protocol analysis method. Missing data will be
handled using last observation carried forward imputation technique.
Discussion: The present single blinded randomised controlled trial has been designed to explore potential
advantages of OMT in the management of newborns’ pain. Currently, based on a patient-centred need-based
approach, this research will be looking at the benefit of osteopathic care rather than the efficacy of a specific
technique or a pre-determined protocol.
Trial registration: The protocol has been registered on ClinicalTrials.gov (NCT02146677) on 20 May 2014.
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Worldwide public health policies are paying considerable
attention to prematurity and neonatal outcomes [1]. To
date, the prevalence of neonatal short-term and long-
term complications are high [2] even more if prematur-
ity is considered [3-5]. Interestingly, several studies have
been published recently considering pain in neonates as
one factor associated with immediate [6,7] and long-term
consequences [3]. Laboratory research has confirmed
these results, highlighting that early repeated tissue injur-
ies alter somatosensory and nociceptive pathways produ-
cing central and peripheral sensitisation [8].
Recent evidence proved the necessity to improve health
care and pain management in newborns [9]. During the
last three decades, the attempt to assess and report pain
in neonates has resulted in the development of dozens of
measurements [9]. The majority of these tools based its
assessment on behavioural, contextual and physiological
indicators. However, for a large proportion of these instru-
ments lack of construct validity and reliability are re-
ported. The only tools which have also been largely
validated in clinical settings are the Behavioural Indicators
of Infant Pain Scale [10] and the Premature Infant Pain
Profile (PIPP) [11]. The PIPP was consistently used in
clinical neonatal settings and research context providing a
reliable tool for neonatal pain assessment [12].
Osteopathic manipulative treatment (OMT) has been
used to treat term and preterm newborns. Recent studies
demonstrated the effectiveness of OMT in reducing
length of stay (LOS) and costs [13] as well as the like-
lihood of gastrointestinal episodes [14]. Moreover, the
absence of adverse events and side effects was widely re-
ported, thus considering the approach to be safe [13,15].
OMT has been extensively used to treat, prevent and
manage pain symptoms. Numerous research has been
published addressing acute and chronic pain in different
medical conditions [16-18]. However, no trials have been
carried out on pain in newborns. The aim of the present
clinical trial is to explore the effectiveness of OMT in re-
ducing pain in a sample of preterms.
Methods/design
The current protocol is designed for a single blinded
placebo-control randomised controlled trial (RCT) aim-
ing at evaluating the extent to which OMT is effective in
reducing pain in preterms. Secondary objectives will be
reduction of LOS and cost-effectiveness.
From 5 May 2014 to 30 September 2015 newborns will
be enrolled in the study at one tertiary neonatal ICU
(NICU). Newborns will enter and be randomised only after
parents or guardians have given written informed consent.
Infants who are admitted to the NICU will be eligible
for inclusion. Inclusion criteria are: being born in Pescara’s
hospital, having a gestational age (GA) between 29 and37 weeks, being of either gender and without clinical and/
or congenital complications. Exclusion criteria will be
applied as follows: lack of guardian consent, having a
gestational age > 37 weeks, being a newborn with HIV
and from HIV seropositive/drug-addicted mother, being
transferred to/from other hospital, the presence of any
congenital or genetical disease, neoplasms, neurological,
cardiovascular, urinary, haematological abnormalities,
proven or suspected necrotising enterocolitis or abdom-
inal obstruction, birth trauma, surgical patients, pneumo-
peritoneum, atelectasis, respiratory distress.Randomisation and masking
Patients will be randomly assigned in a 1:1:1 ratio to
either the OMT, the sham or the control group (Figure 1).
Newborns will be eligible for randomisation from the first
day of life. Block randomisation will be performed accord-
ing to a computer-generated randomisation list using a
block size of nine, and stratified by OMTgroup.
Infants assigned to the study group will be further ran-
domly divided into: OMT group A and OMT group B
(Figure 1).
The coordinating centre will perform and store the
randomisation list and an external consultant will be in
charge of the process. NICU personnel will be unaware
of outcome, study design and patients’ allocation. Only
osteopaths will be aware of patients’ allocation.Osteopathic procedure
Osteopathic care includes an initial structural evaluation
and a final treatment. The structural evaluation is car-
ried out with the newborn lying down in bed and is
aimed at diagnosing somatic dysfunctions [19]. The
osteopathic manipulative treatment includes the applica-
tion of a range of manipulative techniques aimed at
treating the somatic dysfunctions. Techniques chosen
for the present study are balanced ligamentous/mem-
branous tension techniques [15]. The whole session will
last 30 minutes: 10 minutes for evaluation and 20 mi-
nutes for treatment [15].
OMT will be performed by registered osteopaths with
experience in the neonatology field (OMT group A) and
final-year students (OMT group B). Newborns allocated
to the study group will undergo osteopathic care in
addition to usual care.
The sham group will receive only ‘soft touch’, for 30 mi-
nutes, plus routine care, whereas the control group will
receive routine care only.
Osteopathic care and sham therapy will be adminis-
tered once a week according to the treatment group.
OMT groups A and B will enter the NICU on different
days of the week.
Preterms admitted to NICU
Application of inclusion/ exclusion
criteria
Randomisation
of preterm infants included








Figure 1 Flow chart of the study.
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Data will be collected using an ad-hoc platform already
used in previous studies [13,20,21]. Medical records will
be acquired daily by the NICU staff.
Osteopathic records will be reported once a week
when the osteopathic service is provided.
Maternal data will be also include collecting the fol-
lowing information: type of delivery, foetal presentation,
whether placental abruption, pregnancy complications,
single versus multiple gestation, whether premature rup-
ture of membranes and any other complication.
Neonatal data will be gathered using the following pa-
rameters: gender, GA, birth weight, infants small for
GA, neonatal complications (diagnosed at birth and dur-
ing hospitalisation), diagnosis-related group (DRG) at
discharge and reasons for drop out, if any.
A monitoring board will be organised and periodically
will review the safety of data according to survival rate
at discharge and relative risk of developing any clinical
complication. The group sequential method will be uti-
lised to define the rate at which type I errors occur; the
Lan-DeMets generalisation of the O’Brien-Fleming
boundary will be chosen. Interim analyses will be per-
formed. Moreover, the monitoring board will be in
charge of data export.Outcomes
Primary outcome will be the mean difference in baseline
score changes of PIPP questionnaire between discharge
and entry among the three groups.
Secondary outcomes will include:
 mean difference in PIPP questionnaire scores before
and after each treatment
 mean difference in LOS measured in days between
the three groups
 mean difference in costs between the three groups
 mean difference in PIPP questionnaire scores
between the two OMT subgroups
 mean difference in LOS measured in days between
the two OMT subgroups
 mean difference in costs between the two OMT
subgroups
 difference in the risk of adverse events and side
effects between the three groups
 average daily weight gain measured in grams
Measures
The PIPP is a seven-item multidimensional (composite)
measure of pain, largely used to assess acute pain in in-
fants [11] and extensively validated for both preterm and
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ally derived and are categorised as: contextual ((GA) and
behavioural state (BS)), physiological (heart rate and
oxygen saturation) and behavioural (facial actions). Nu-
meric scores, reflecting baseline changes and based on
an empirically 4-point scale (0, 1, 2, and 3), are provided
for physiological and behavioural items. Conversely, the
contextual items (GA and BS) have a reversed score (3,
2, 1, and 0) accounting for physiological differences re-
lated to prematurity. The maximum PIPP score is 21 for
infants < 28 weeks GA and 18 for full-term newborns.
Considering LOS, according to international guide-
lines, well-determined discharge parameters are required
and listed as follows: coordinated breathing, swallowing
and sucking while feeding; stability of cardiorespiratory
function; sustained weight gain and body heat at room
temperature [23].
Regarding NICU costs, costs per day are calculated ac-
cording to local authorities, multiplied by the days of
hospitalisation. Costs are estimated in euros per day.
Statistical analysis
According to Stevens et al. [11] the mean PIPP score for
a painful procedure is 12.9 (standard deviation (SD), 3.4)
and 6.0 (SD, 2.7) for a non-painful procedure. For a heel
stick, the mean score is 10.3 (SD, 4.5) and 6.3 (SD, 3.2)
for a simulated handling. However, as there is a lack of
clinical trials in complementary medicine and/or manual
disciplines, the sample size is computed considering an
effect size (f ) of 0.30, a statistical power of 0.80 and an
α-level equal to 0.05 to produce a sample size of 37 per
group. To prevent loss of power, the sample size is in-
creased up to 40 subjects per group (total sample N = 120).
The primary analysis of the present clinical trial will
be conducted according to per-protocol principle and
intention-to-treat. Missing data will be handled using
the last observation carried forward imputation tech-
nique. Arithmetic means and SD as well as median, per-
centage and range will be used to describe the general
characteristics of the study population. Univariate statis-
tical tests, Student’s t-test, analysis of variance (ANOVA)
and chi square test, will be performed to compare the
study groups and control group at the baseline. A linear
mixed effect model will be used to evaluate the PIPP
score across groups. Data will be analysed within and be-
tween the three study groups. Furthermore, a linear re-
gression model will be applied to study the independent
effect of OMT on primary and secondary endpoints be-
tween OMT groups A and B. Two-tailed P-values of less
than 0.05 are considered to indicate statistical difference.
To describe imbalances between groups, mean or relative
risk with 95% CI will be used. Effect sizes will be computed
stratifying by gestational age. R statistical programme
(Vienna, Austria) will be used for data analysis [24].Cost analysis
Ordinary least squares regression will be performed to
quantify the cost of hospitalisation among preterms after
adjusting for gender, GA, LOS, birth weight, OMT, time
to first OMT, and DRG. Cost data is extracted from
2014 to 2015 administrative databases of the Regional
Office of the Ministry of Health of Abruzzo where the
NICU of the present RCT is located.
To calculate the precise cost, the reimbursement allo-
cated to each DRG from the Istituto Superiore di Sanità
(National Healthcare Institute) is used. Specifically DRGs
and reimbursements considered are 386 (€12.932.69),
387 (€7.450.09) and 388 (€3.757.22) [25].
As for the study group, OMT costs are theoretically
set at €20.00 considering fees from health insurance com-
panies [26].
Cost estimates will be adjusted for inflation to 2014
euro value using the Medical Component of the Con-
sumer Price Index.Ethics
The approval of the Ethics Committee of the local health
agency of Pescara (number 78/2013) has been obtained
and the protocol has been registered on ClinicalTrials.
gov (NCT02146677) on 20 May 2014. No disadvantages
for the intervention are expected and no possible ad-
verse events and side effects owing to OMT are pre-
dicted as confirmed by the recent osteopathic literature
[13,15]. In any case, side effects and reason for drop out
will be recorded during the research period and dis-
cussed in the final paper.Discussion
The present single blinded RCT has been designed to ex-
plore potential advantages of OMT in the management of
newborns’ pain. Currently, based on a patient-centred
need-based approach, this research will be looking at the
benefit of OMT rather than the efficacy of a specific tech-
nique or a pre-determined protocol. Moreover, it will
attempt to confirm the effectiveness of OMT on LOS-
shortening using a larger experimental study design and
to corroborate the absence of placebo effects in newborns.
Furthermore, it will explore potential differences between
expert osteopaths and final-year students on the effective-
ness of OMT.
To date, no osteopathic trial has been carried out in this
field attempting to quantify the benefits of OMT in new-
borns’ pain using rigorous procedures and ‘gold-standard’
methods for clinical trials. This will be the first concrete
experimental trial addressing this outcome. The expected
advantages from the present trial will be reduction of pain,
shorter LOS and lower neonatal costs in the OMT groups
compared to sham and control groups.
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The outcomes of the present research will be published
in peer-reviewed journals and presented at congresses.
The trial will be reported in accordance with the Con-
solidated Standards of Reporting Trials (CONSORT)
recommendations.
Trial status
The present protocol is for an ongoing research.
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